Rejected Applicant's Petition Says Agency Kept 'Secret' Filing System

For over 14 years, the National Science Foundation has systematically deprived its grant applicants of certain basic legal rights that Congress intended them to have and which other granting agencies, such as the National Institutes of Health have made more of an effort to protect. Because of NSF’s circumvention of these rights, many scientists may have been denied grants for improper reasons—due to conflicts of interest, or because of blatantly erroneous information—without

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

For over 14 years, the National Science Foundation has systematically deprived its grant applicants of certain basic legal rights that Congress intended them to have and which other granting agencies, such as the National Institutes of Health have made more of an effort to protect. Because of NSF’s circumvention of these rights, many scientists may have been denied grants for improper reasons—due to conflicts of interest, or because of blatantly erroneous information—without even realizing it.

To rectify this situation, we recently submitted an extensive petition to NSF, asking it to make some modest but essential changes in its peer review system—changes that would undermine none of the fundamental principles on which a peer review system is based, but which would make it much fairer and more accountable to grant applicants. It is in the interest of every person who has ever submitted a grant application to NSF. or who may ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jon Kalb

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide